http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1674849-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40d2d8436b54c14754e57e3fba2ad74b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 1989-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1991-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_756cc8214308cdd60718b387bace17d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd9781c8791c8e38e47812ed228c8425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_343bc5f700069103883d1f412911c5d7 |
| publicationDate | 1991-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1674849-A1 |
| titleOfInvention | Method for treatment of psoriasis |
| abstract | The invention relates to medicine, in particular to dermatology. The goal is to reduce the duration of treatment while reducing the dose of radiation and the complications of photochemotherapy. To this end, in a known method of photochemotherapy, the diseases additionally include immunocorrective agents after examining the immune status of the organism. With a decrease in the content of B-lymphocytes, T-suppressors by 30% or more and a simultaneous increase in T-helpers, dalargin is introduced, and with an increase in the level of B-lymphocytes, T-suppressors and a simultaneous decrease in T-helpers, thymalin in daily dose of 5 mg or T-activin in a daily dose of 50 mg. 1 tab. |
| priorityDate | 1989-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.